Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Montag

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2010
Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasisHilary A Kenny, Payton Leonhardt, Andras Ladanyi, et al.
Gynecologic Oncology|December 26, 2008
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group studyHoward D Homesley, Virginia Filiaci, Susan K Gibbons, et al.
Cancer Research|November 20, 2002
Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinomaS Diane Yamada, Jonathan A Hickson, Yancey Hrobowski, et al.
Cancer Research|January 10, 2002
Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic diseasePeter Kufer, Alfred Zippelius, Ralf Lutterbüse, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2002
The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosisBeverly W Baron, John Anastasi, Michael J Thirman, et al.
Cancer Discovery|November 19, 2016
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian TubeMark A Eckert, Shawn Pan, Kyle M Hernandez, et al.
Oncogene|February 6, 2018
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasisAndras Ladanyi, Abir Mukherjee, Hilary A Kenny, et al.
Cell|September 23, 2018
Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian CancerFabian Coscia, Ernst Lengyel, Jaikumar Duraiswamy, et al.
Cancer Research|April 3, 2008
Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic targetKenjiro Sawada, Anirban K Mitra, A Reza Radjabi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2004
The human BCL6 transgene promotes the development of lymphomas in the mouseBeverly W Baron, John Anastasi, Anthony Montag, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2010
Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasisHilary A Kenny, Payton Leonhardt, Andras Ladanyi, et al.
Gynecologic Oncology|December 26, 2008
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group studyHoward D Homesley, Virginia Filiaci, Susan K Gibbons, et al.
Cancer Research|November 20, 2002
Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinomaS Diane Yamada, Jonathan A Hickson, Yancey Hrobowski, et al.
Cancer Research|January 10, 2002
Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic diseasePeter Kufer, Alfred Zippelius, Ralf Lutterbüse, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2002
The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosisBeverly W Baron, John Anastasi, Michael J Thirman, et al.
Cancer Discovery|November 19, 2016
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian TubeMark A Eckert, Shawn Pan, Kyle M Hernandez, et al.
Oncogene|February 6, 2018
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasisAndras Ladanyi, Abir Mukherjee, Hilary A Kenny, et al.
Cell|September 23, 2018
Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian CancerFabian Coscia, Ernst Lengyel, Jaikumar Duraiswamy, et al.
Cancer Research|April 3, 2008
Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic targetKenjiro Sawada, Anirban K Mitra, A Reza Radjabi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2004
The human BCL6 transgene promotes the development of lymphomas in the mouseBeverly W Baron, John Anastasi, Anthony Montag, et al.
Pageof 4